Cognition Therapeutics CGTX
NASDAQ CGTX
$0.89 -0.07 (-7.17%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cognition Therapeutics (CGTX) Share-based Compensation (2020 - 2026)

Updated

Cognition Therapeutics (CGTX) recorded Share-based Compensation of $319,000 in Q2 2026, down 48.6% from $621,000 a year earlier and down 3.3% from the prior quarter.

Analysis

Cognition Therapeutics (CGTX) Share-based Compensation (2020 - 2026) Analysis & Trends

On a TTM basis, Cognition Therapeutics' Share-based Compensation came in at $1.53 million as of Jun 30, 2026, down 42.0% year-over-year; for FY2025, it was $2.09 million, down 44.3% from FY2024.

  • Annual Share-based Compensation has a five-year compound annual growth rate of 34.5% (FY2020 to FY2025).
  • Across earlier years, Share-based Compensation came in at $3.75 million in FY2024 (-13.9%), $4.35 million in FY2023 (+21.9%), $3.57 million in FY2022 (-31.1%) and $5.18 million in FY2021 (+991.2%).
  • The Q2 2026 figure is the lowest quarterly Share-based Compensation since Q3 2021.
  • On a year-over-year basis, Share-based Compensation has declined for eight consecutive quarters, with an average decline of 41.2% over the last eight quarters.
  • Peak year-over-year performance for Share-based Compensation in the last five years was growth of 979.2% in Q3 2022, against a decline of 81.7% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $330,000 (Q1 2026), $358,000 (Q4 2025) and $522,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 458.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 166.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 231.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 170.20 Mn
10 Cognition Therapeutics 91.25 Mn 91.25 Mn - 319,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 319,000.00
Mar 31, 2026 330,000.00
Dec 31, 2025 358,000.00
Sep 30, 2025 522,000.00
Jun 30, 2025 621,000.00
Mar 31, 2025 586,000.00
Dec 31, 2024 534,000.00
Sep 30, 2024 896,000.00
Jun 30, 2024 1.15 Mn
Mar 31, 2024 1.17 Mn
Dec 31, 2023 1.07 Mn
Sep 30, 2023 1.07 Mn
Jun 30, 2023 1.03 Mn
Mar 31, 2023 1.19 Mn
Dec 31, 2022 902,000.00
Sep 30, 2022 777,000.00
Jun 30, 2022 892,000.00
Mar 31, 2022 1.00 Mn
Dec 31, 2021 4.92 Mn
Sep 30, 2021 72,000.00
API Access

Cognition Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CGTX&period=max&api_key=YOUR_API_KEY